Disability of People With Fibromyalgia in Poland
Assessment of Functioning and Disability of People With Fibrimyalgia in Poland
1 other identifier
observational
700
1 country
1
Brief Summary
Fibromyalgia is a syndrome characterized by chronic, generalized pain in muscles and joints with the presence of characteristic, symmetrically occurring so-called "tender points" - areas of the body that are excessively sensitive to pressure. The condition is associated with a feeling of chronic fatigue, mood and sleep disturbances and a sensation of body stiffness. These complaints are bothersome and significantly impair patients' functioning in every aspect of their lives. There are few studies evaluating the functioning and disability of people with fibromyalgia. No such study has been conducted in Poland to date. Therefore, the purpose of this study is to evaluate the functioning and disability of fibromyalgia patients and the relationship of the level of disability with selected factors, such as pain intensity, emotional state, sleep quality, etc.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2024
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedStudy Start
First participant enrolled
April 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedApril 16, 2024
April 1, 2024
16 days
February 28, 2024
April 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
disability
Disability assessment using the WHO Disability Assessment Schedule. (WHODAS 2.0). The obtained results are converted on the scale from 0 to 100. When assessing the level of disability with the WHODAS 2.0, the following scale (consistent with the ICF) was used: no disability or an insufficient problem (0-4%), mild disability or a small problem (5-24%), moderate disability or a significant problem (25-49%), severe disability or a big problem (50-95%), and extreme disability or a total problem (96-100%).
2024-01/2024-05
Secondary Outcomes (3)
functioning
2024-01/2024-05
depression
2024-01/2024-05
Sociodemographic data
2024-01/2024-05
Study Arms (1)
people with fibromyalgia
People with fibromyalgia in Poland. The study does not include any intervention. The collected data, in a cross-sectional study, are intended to assess the functioning and disability of people with fibromyalgia using standardized questionnaires such as: WHODAS 2.0, FIQ, BDI.
Eligibility Criteria
Adults with fibromyalgia in Poland.
You may qualify if:
- People aged 18 and over
- People suffering from fibromyalgia
- People who give informed consent to participate in the study
You may not qualify if:
- Tłumaczenie
- Underage persons
- People without fibromyalgia
- People who do not give informed consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Rzeszow
Rzeszów, Podkarpackie Voivodeship, 35-310, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agnieszka Sozańska
University of Rzeszow
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- dr hab. n. o zdr., prof. UR
Study Record Dates
First Submitted
February 28, 2024
First Posted
March 6, 2024
Study Start
April 15, 2024
Primary Completion
May 1, 2024
Study Completion
November 1, 2024
Last Updated
April 16, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share